Microscopic view of the COVID-19 virus

NIBIB's goal is to accelerate research, translation, and commercialization of technologies that will provide solutions to the COVID-19 pandemic.

NIBIB is overseeing the Rapid Acceleration of Diagnostic Technologies (RADx℠ Tech) program, a $500 million effort to significantly increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID-19.  In addition to this major effort, NIBIB is supporting several areas of technology development outlined in three Notices of Special Interest (NOSIs).

Information about NIBIB’s effort to increase diagnostic testing capacity for SARS-CoV-2.